| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $11.4M | +176.7% | +263.8% |
| Cost of Revenue | $3.4M | +14.0% | +19.8% |
| Gross Profit | $1.6M | +45.0% | +534.7% |
| R&D Expense | $301K | -1.2% | -24.1% |
| SG&A Expense | $5.9M | +38.4% | +57.2% |
| Operating Income | -$4.8M | -32.5% | -22.7% |
| Net Income | -$4.9M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $3.8M | +170.0% | +102.5% |
| Accounts Receivable | $515K | +74.0% | +10.4% |
| Inventory | $6.8M | +16.2% | +11.4% |
| Current Assets | $12.4M | +45.8% | +39.3% |
| Total Assets | $27.0M | +14.7% | +8.5% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$11.2M | — | — |
| Capital Expenditures | $634K | — | — |
| Investing Cash Flow | -$1.1M | — | — |
| Financing Cash Flow | $11.1M | — | — |
| Free Cash Flow | -$11.8M | — | — |
| -32.0% |
| -19.2% |
| EPS (Basic) | -$0.75 | -5.6% | -435.7% |
| EPS (Diluted) | -$0.75 | -5.6% | -435.7% |
| $6.1M |
| +62.5% |
| +101.8% |
| Long-term Debt | $2.9M | +16.3% | — |
| Total Liabilities | $7.3M | +16.1% | -15.2% |
| Stockholders' Equity | $19.8M | +14.2% | +20.9% |